← Eichor
Study identifier: NCT06276634 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intermittent Hypoxia in Persons With Multiple Sclerosis

Condition: Multiple Sclerosis · Multiple Sclerosis-Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive  ·  Sponsor: Shirley Ryan AbilityLab

PhaseNA
Planned participants21
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS). This intervention with low levels of oxygen is called Acute Intermittent Hypoxia (AIH), the levels of oxygen experienced are similar to breathing the air on a tall mountain, for less than 1 minute at a time. Previous studies have shown that AIH is a safe and effective way to increase strength in persons with MS. Here the investigators aim to look at brain activation and ankle strength before and after AIH to gain a better understanding of how the AIH may improve strength in those persons with MS.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Barry, MS, CCRC  ·  3122381435  ·  abarry@sralab.org

Always discuss trial participation with your own doctor first.

Locations (1)

Shirley Ryan AbilityLabChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06276634